Il rischio trombotico ed emorragico nelle malattie mieloproliferative croniche Ph negative


https://doi.org/10.4081/hmr.v2i6.389
Vol. 2 No. 6: Malattie mieloproliferative croniche: policitemia, trombocitemia, mielofibrosi," Pavia, Italy, March 2006
Published: June 8, 2009
Abstract Views: 286
PDF: 2113
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Le malattie mieloproliferative croniche Philadelphia negative (cMPD Ph-) nelle quali trombosi ed emorragie hanno notevole rilevanza clinica sono la Policitemia Vera (PV), la Trombocitemia Essenziale (TE) e la Mielofibrosi con Metaplasia Mieloide (MMM). Alla terapia e/o alla profilassi delle complicanze vascolari è finalizzata la messa in atto di trattamenti dalla cui efficacia, sicurezza e tollerabilità dipendono in buona misura quantità e qualità di vita dei pazienti. La valutazione del rapporto costo-beneficio dei vari trattamenti impone la precisa definizione delle malattie considerate, l’inquadramento fisiopatologico delle manifestazioni cliniche nonchè l’identificazione del loro peso prognostico.

Supporting Agencies


Gugliotta, L., Tieghi, A., & Bulgarelli, S. (2009). Il rischio trombotico ed emorragico nelle malattie mieloproliferative croniche Ph negative. Hematology Meeting Reports (formerly Haematologica Reports), 2(6). https://doi.org/10.4081/hmr.v2i6.389
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC